Breast Cancer Research and Treatment

, Volume 53, Issue 2, pp 121–135

Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (CIN III).

  • Elin M. Hennig
  • Zhenhe Suo
  • Steinar Thoresen
  • Ruth Holm
  • Stener Kvinnsland
  • Jahn M. Nesland
Article

Abstract

Women with both a history of high grade cervical intraepithelial neoplasia (CIN III) and breast carcinoma as second primary cancer were selected for studying the presence of HPV in breast carcinomas. Paraffin embedded material from 38 patients with 41 breast carcinoma cases after CIN III were examined by polymerase chain reaction (PCR) and in situ hybridization. By PCR we detected HPV 16 DNA in 19 out of 41 cases (46%) of the breast carcinomas. One case proved to be HPV 16 positive also by in situ hybridization. HPV 16 was also detected in 32 out of the 38 patients with CIN III (84%). All HPV 16 positive breast carcinomas were HPV 16 positive in their corresponding CIN III lesions. Eight patients with diagnosed breast cancer before the CIN III lesions were used as controls. None of these had HPV positive breast carcinomas. No cases were positive for HPV 11, 18, or 33. HPV 16 was detected in the primary tumours, in local metastases from HPV 16 positive tumours, in a distant HPV 16 positive breast carcinoma metastasis to the colon, and in other primary cancers in patients with HPV 16 positive breast carcinomas and HPV 16 positive CIN III. Estrogen and progesterone receptors were quantified in the HPV positive and HPV negative breast carcinomas, and there was no significant difference in the fraction positive in the two groups. Oncogenic HPV DNA might be transported from an original site of infection to other organs by blood or lymph, and possibly be a factor in the development of cancer in different organs.

HPV 16 breast cancer CIN III PCR southern blot in situ hybridization 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    IARC (WHO): Cancer incidence in five continents. Vol 6: 957, 1992 (Lyon)Google Scholar
  2. 2.
    APMIS: Prediction of cancer mortality in the Nordic countries up to the years 2000 and 2010. Vol 103 (Suppl 49), 1995Google Scholar
  3. 3.
    Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King M-C: Linkage of early onset familial breast cancer to chromosome 17q21. Science 250: 1684–1689, 1990Google Scholar
  4. 4.
    Easton DF, Bishop DT, Ford D, Crockford GP:Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The breast cancer linkage consortium. Am J Hum Gen 52: 678–701, 1993Google Scholar
  5. 5.
    Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, et al.: Localization of a breast cancer susceptibility gene, BRCA 2, to chromosome 13q 12–13. Science 265: 2088–2090, 1994Google Scholar
  6. 6.
    Cornelisse CJ, Cornelis RS, Devilee P: Genes responsible for familial breast cancer. Path Res Pract 192: 684–693, 1996Google Scholar
  7. 7.
    Medina D: Preneoplastic lesions in murine mammary cancer. Cancer Res 36 (7 PT 2): 2589–2595, 1996Google Scholar
  8. 8.
    Dickson C: Role of the Int-genes in murine mammary tumor development and implications for human breast cancer. Int J Cancer 5 (suppl): 51–54, 1990Google Scholar
  9. 9.
    Vokaer A:Viruses and mammary carcinogenesis. Jgynecol Obstet Biol Reprod Paris 4 (suppl 2): 199–205, 1975Google Scholar
  10. 10.
    IARC (WHO): Cancer incidence in five continents. Vol 6: 960, 1992 (Lyon)Google Scholar
  11. 11.
    IARC (WHO): Monographs on the evaluation of carcinogenic risks to humans. Human papillomaviruses. Vol 64: 90–102, 1995 (Lyon)Google Scholar
  12. 12.
    Scholefield JH, Palmer JG, Sheperd NA, Love S, Miller KJ, Northover JM: Clinical and pathological correlates of HPV type 16 DNA in anal cancer. Int J Colorect Dis 5: 219–222, 1990Google Scholar
  13. 13.
    Scholefield JH, Kerr IB, Sheperd NA, Miller KJ, Bloomfield R, Nortover JM: Human papillomavirus type 16 DNA in anal cancers from six different countries. Gut 32: 674–676, 1991Google Scholar
  14. 14.
    Shibutani YF, Schoenberg MP, Carpiniello VL, Malloy TR: Human papillomavirus associated with bladder cancer. Urology 40: 15–17, 1992Google Scholar
  15. 15.
    Agliano AM, Gradiglione A, Gazzaniga P, Napolitano M, Vercillo R, Albonici L, Naso G, Frati L, Vecchione A: High frequency of human papillomavirus detection in urinary bladder cancer. Urol Int 53: 125–129, 1994Google Scholar
  16. 16.
    Lopez-Beltran A, Escudero AL, Carrasco-Aznar JC, Vicioso-Recio L: Human papillomavirus infection and transitional cell carcinoma of the bladder. Immunohistochemistry and in situ hybridization. Pathol Res Pract 192: 154–159, 1996Google Scholar
  17. 17.
    Watts SL, Brewer EE, Fry TL: Human papillomavirus DNA types in squamous cell carcinomas of the head and neck. Oral Surg Oral Med Oral Pathol 71: 701–707, 1991Google Scholar
  18. 18.
    Kasperbauer JL, O'Halloran GL, Espy MJ, Smith TF, Lewis JE: Polymerase chain reaction (PCR) identification of human papillomavirus (HPV) DNA in verrucous carcinomas of the larynx. Laryngoscope 103: 416–420, 1993Google Scholar
  19. 19.
    Chang F, Syrjanen S, Shen Q, Wang L, Wang D, Syrja-nen K: Human papillomavirus involvement in esophagealprecancerous lesions and squamous cell carcinomas as evi-denced by microscopy and different DNAtechniques. Scand J Gastroenterol 27: 553–563, 1992Google Scholar
  20. 20.
    Togawa K, Jaskiewicz K, Takahashi H, Meltzer SJ, Rustgi AK: Human papillomavirus DNA sequences in esophagus squamous cell carcinoma. Gastroenterology 107: 128–136, 1994Google Scholar
  21. 21.
    Bejui-Thivolet F, Chardonnet Y, Patricot L: Human papillomavirus type 11 DNA in papillomas and squamous cell lung carcinoma. Virchows Arch (A) 417: 457–461, 1990Google Scholar
  22. 22.
    Yousem SA, Ohori VP, Sonmez-Alpan E: Occurrence of human papillomavirus DNA in primary lung neoplasms. Cancer 69: 693–697, 1992Google Scholar
  23. 23.
    Noutsou A, Koffa M, Ergazaki M, Siafakas NM, Spandidos DA: Detection of human papillomavirus (HPV) and K-ras mutations in human lung carcinomas. Int J Onc 8: 1089–1093, 1996Google Scholar
  24. 24.
    Gordon AN, Bornstein J, Kaufman RH, Estrada RG, Adams E, Adler-Storthz K: Human papillomavirus associated with adenocarcinoma and adenosquamous carcinoma of the 134 EM Hennig et al. cervix: analysis by in situ hybridization. Gynecol Oncol 35: 345–348, 1989Google Scholar
  25. 25.
    Di Lonardo A, Venuti A, Marcante ML: Human papillomavirus in breast cancer. Breast Cancer Res Treat 21: 95–100, 1992Google Scholar
  26. 26.
    Pater MM, Mittal R, Pater A: Role of steroid hormones in potentiating transformation of cervical cells by human papillomaviruses. Trends Microbiol 2: 229–234, 1994Google Scholar
  27. 27.
    Mittal R, Pater MM:Multiple human papillomavirus type 16 glucocorticoid response elements for transformation, transient expression, and DNA-protein interactions. J Virol 67: 5656–5659, 1993Google Scholar
  28. 28.
    Chan S-Y, Klock G, Bernard HU: Progesterone and glucocorticoid response elements occur in the long control regions of several human papillomaviruses involved in anogenital neoplasia. J Virol 63: 3261–3269, 1989Google Scholar
  29. 29.
    Chen YH, Huang LH, Chen TM: Differential effects of progestins and estrogens on long control regions of human papillomaviruses type 16 and 18. Biochem Biophys Res Commun 224: 651–659, 1996Google Scholar
  30. 30.
    Pater A, Bayatpour M, Pater MM: Oncogenic transformation by human papillomavirus type 16 deoxyribonucleic acid in the presence of progesterone and progestins from oral contraceptives. Am J Obstet Gynecol 162: 1099–2003, 1990Google Scholar
  31. 31.
    Monsonego J, Magdelenat H, Catalan F, Coscas Y, Zerat L, Sastre X: Estrogen and progesterone receptors in cervical human papillomavirus related lesions. Int J Cancer 48: 533–539, 1991Google Scholar
  32. 32.
    Band V, Zajchowski D, Kuleska V, Sager R: Human papillomavirus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements. Proc Natl Acad Sci USA 88: 463–467, 1990Google Scholar
  33. 33.
    Pao CC, Lin SS, Lin CY, Maa JS, Lai C, Hsieh TT: Identification of human papillomavirus DNA sequences in peripheral blood mononuclear cells. Am J Clin Pathol 95: 540–546, 1991Google Scholar
  34. 34.
    Mies C, Houldsworth J, Changanti RSK: Extraction ofDNA from paraffin blocks for southern-blot analysis. Am J Surg Pathol 15: 169–194, 1991Google Scholar
  35. 35.
    Shibata DK Arnheim N, Martin WJ: Detection of human papillomavirus in paraffin embedded tissue by using the polymerase chain reaction. J Exp Med 167: 225–230, 1988Google Scholar
  36. 36.
    Human papillomaviruses. Theoretical Biology and Biophysics, Los Alamos National Laboratory, New Mexico, USA, 1994Google Scholar
  37. 37.
    de Roda Husman AM, Waalboomers JMM, van den Brule AJC, Meijer CJLM, Snijders PJF: The use of general primers GP5 and GP6 elongated at their 30 ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76: 1057–1062, 1995Google Scholar
  38. 38.
    Arends MJ, Donaldson YK, Duvall E, Wyline AH, Bird CC: HPV in full thickness cervical biopsies: High prevalence in CIN 2 and CIN 3 detected by a sensitive PCR method. J Pathol 165: 301–309, 1991Google Scholar
  39. 39.
    Karlsen F, Kalantari M, Jenkins A, Pettersen K, Kristensen G, Holm R, Johansson B, Hagmar B: Use of multiple PCR sets for optimal detection of human papillomavirus. J Clin Microbiol 34: 2095–2100, 1996Google Scholar
  40. 40.
    Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Ehrlich HA, Arnheim N: Enzymatic amplification of _-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230: 1350–1354, 1985Google Scholar
  41. 41.
    D¨urst M, Gissmann L, Ikenberg H, zur Hausen H:Apapillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 80: 3812–3815, 1983Google Scholar
  42. 42.
    Boshart M, Gissmann L, Ikenberg H, Kleinheinz A, Scheurlen W, zur Hausen H: A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J 3: 1151–1157, 1984Google Scholar
  43. 43.
    Gissmann L, Diehl V, Schultz-Coulon HJ, zur Hausen H: Molecular cloning and characterization of human papillomavirus DNA derived from laryngeal papilloma. J Virol 44: 393–400, 1982Google Scholar
  44. 44.
    Holm R, Karlsen K, Nesland JM: In situ hybridization with non-isotopic probes using different detection systems. Mod Pathol 5: 315–320, 1992Google Scholar
  45. 45.
    Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. 1. The value of histological grade in breast cancer.Experience from a large study with long-term-follow up. Histopathology 19: 403–410, 1991Google Scholar
  46. 46.
    Wrede D, Luqmani YA, Coombs RC, Vousden KH: Absence of HPV 16 and 18 in breast cancer. Br J Cancer 65: 891–894, 1992Google Scholar
  47. 47.
    Bratthauer GL, Tavassoli FA, O'Leary TJ: Etiology of breast carcinoma: no apparent role for papillomavirus types 6/11/16/18. Path Res Pract 188: 384–386, 1992Google Scholar
  48. 48.
    Gopalakrishna V, Singh UR, Sodhani P, Sharma ST, Hedau AK, Mandal AK, Das BC: Absence of human papillomavirus DNA in breast cancer as revealed by polymerase chain reaction. Breast Cancer Res Treat 39: 197–202, 1996Google Scholar
  49. 49.
    Yee C, Krishnan-Hewlett I, Baker CC, Schlegel R, Howley PM: Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines.AmJ Pathol 119: 361–366, 1985Google Scholar
  50. 50.
    Masih AS, Stoler MH, Farrow GM, Johansson SL: Human papillomavirus in penile squamous cell lesions. A comparison of an isotopic RNA and two commercial nonisotopic DNA in situ hybridization methods. Arch Pathol Lab Med 117: 302–307, 1993Google Scholar
  51. 51.
    Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higechi R, Horn GT, Mullis KB, Erlich HA: Primer directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239: 487–491, 1988Google Scholar
  52. 52.
    Ogura H, Watanabe S, Fukishima K, Masuda Y, Fujiwara T, Yabe Y: Human papillomavirus DNA in squamous cell carcinoma of the respiratory and upper digestive tracts. Jpn J Clin Oncol 23: 221–225, 1993Google Scholar
  53. 53.
    Popper H, el Shabrawi Y, Wockel W, Hofler G, Kenner L, Juttner-Smolle FM, Pongratz MG:Prognostic importance of human papillomavirus typing in squamous cell papilloma of the bronchus: comparision of in situ hybridization and the polymerase chain reaction. Hum Pathol 25: 1191–1197, 1994Google Scholar
  54. 54.
    Rabkin CS, Biggar RJ, Melbye M, Curtis RE: Second primary cancers following anal and cervical carcinoma: evidence of shared etiological factors. Am J Epidem 136: 54–58, 1994Google Scholar
  55. 55.
    Bjørge T, Hennig EM, Skare GB, Søreide O, Thoresen S: Second primary cancers in patients with carcinoma in situ of the uterine cervix. The Norwegian experience 1970–1992. Int J Cancer 62: 29–33, 1995Google Scholar
  56. 56.
    Levi F, Randimson L, LaVecchia C, Franceschi S: Incidence of invasive cancers following carcinoma of the cervix. Br J Cancer 74: 1321–1323, 1996Google Scholar
  57. 57.
    Sturgeon SR, Curtis RE, Johnson K, Ries L, Brinton LA: Second primary cancers after vulvar and vaginal cancers. Am J Obset Gyn 174: 929–933, 1996Google Scholar
  58. 58.
    Majewski S, Jablonska S: Human papillomavirusassociated tumors of the skin and mucosa. J Am Acad Dermatol 36: 659–685, 1997Google Scholar
  59. 59.
    Mc Neil C: News: HPV vaccines for cervical cancer move toward clinic, encounter social issues. J Natl Cancer Inst 89: 1664–1666, 1997Google Scholar
  60. 60.
    Helland A, Børresen AL, Kaern J, Rønningen KS, Thorsby E:HLAantigens and cervical carcinoma. Nature 356 (Letter to editor): 23, 1992Google Scholar
  61. 61.
    Tay SK, Jenkins D, Maddox P, Campion M, Singer A: Subpopulation of Langerhans' cells in cervical neoplasia. Br J Obstet Gynaecol 94: 10–15, 1987Google Scholar
  62. 62.
    Apple RJ, Erlich HA, Klitz W, Manos MM, Becker TM, Wheeler CM: HLA DR-DQ association with cervical carcinoma shows papillomavirus-type specificity. Nat Genet 6: 157–162, 1994Google Scholar
  63. 63.
    Tay SK, Jenkins D, Maddox P, Singer A: Lymphocyte phenotypes in cervical intraepithelial neoplasia and human papillomavirus infection. Br J Obstet Gynaecol 94: 16–21, 1987Google Scholar
  64. 64.
    Petry KU, Scheffel D, Bode U, Gabrysiak T, Kochel H, Kupsch E, Glaubitz M, Niesert S, Kuhnle H, Schedel I: Cellular immunodeficiency enhances the progression of human papillomavirus associated cervical lesions. Int Jcancer 67: 836–840, 1994Google Scholar
  65. 65.
    zur Hausen H: Intracellular surveillance of persisting viral infections. Human genital cancer results from deficient cellular control of papillomavirus gene expression. Lancet 2: 489–491, 1986Google Scholar
  66. 66.
    Majewski S, Jablonska S: Epidermodysplasia verruciformis as amodel of human papillomavirus induced genetic cancer of the skin. Arch Dermatol 131: 1312–1318, 1995Google Scholar
  67. 67.
    Perera FP, Estabrook A, Hewer A, Channing K, Rundle A, Mooney LA, Whyatt R, Phillips DH: Cancer DNA adducts in human breast tissue. Cancer Epidemiol Biomarkers Prev 4: 233–238, 1995Google Scholar
  68. 68.
    Simons AM, Phillips DH, Coleman DV: DNA adduct assay in cervical epithelium.Diagn Cytopathol 10: 284–288, 1994Google Scholar
  69. 69.
    zur Hausen H: Papillomavirus infections – a major cause of human cancers. Biochim Biophys Acta 1288: F55–F78, 1996Google Scholar

Copyright information

© Kluwer Academic Publishers 1999

Authors and Affiliations

  • Elin M. Hennig
    • 1
  • Zhenhe Suo
    • 1
  • Steinar Thoresen
    • 2
  • Ruth Holm
    • 1
  • Stener Kvinnsland
    • 3
  • Jahn M. Nesland
    • 1
  1. 1.Department of Pathology and Institute for Cancer ResearchThe Norwegian Radium Hospital, University of OsloMontebello, OsloNorway
  2. 2.The Cancer Registry of NorwayMontebello, OsloNorway
  3. 3.Department of OncologyThe Norwegian Radium Hospital, University of OsloMontebello, OsloNorway

Personalised recommendations